Quince Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.6M | $133.2M | $69.7M |
| FY2022 | $3.3M | $103.9M | $44.6M |
| FY2023 | $82.8M | $167.9M | $20.8M |
| FY2024 | $84.3M | $114.5M | $6.2M |
| FY2025 | $129.2M | $93.5M | $5.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.6M | $133.2M | $69.7M |
| FY2022 | $3.3M | $103.9M | $44.6M |
| FY2023 | $82.8M | $167.9M | $20.8M |
| FY2024 | $84.3M | $114.5M | $6.2M |
| FY2025 | $129.2M | $93.5M | $5.8M |